KLRB1 and neoplasm: Among TME-related prognostic signature, KLRB1, SCL27A2, PXDNL, LINC02038, IGHV1-12, IGKV1OR2-108 were directly related to tumor immunity to a certain extent, reflecting the characteristics of natural killer cells, natural killer T cells and other immune cells.